Kristopher J. Hansen
Expertise in
20
conditions

Dr. Kristopher J. Hansen

Hematology Oncology
800 Howard Avenue, Suite 1, 
Altoona, PA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
20
conditions
800 Howard Avenue, Suite 1, 
Altoona, PA 

Overview

Kristopher Hansen, DO, specializes in hematology oncology and is board-certified in internal medicine and medical oncology by the American Board of Internal Medicine. He is affiliated with UPMC Altoona. Dr. Hansen completed his fellowship at the University of Kansas School of Medicine, residency at Wake Forest University School of Medicine and medical degree at Edward Via College of Osteopathic Medicine.

Dr. Hansen is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Lung Cancer, and Pleuropulmonary Blastoma.

Dr. Hansen is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 2 clinical trials. Dr. Hansen is currently accepting new patients.

Specialties

Hematology Oncology

Licenses

Internal Medicine in VA

Board Certifications

American Board Of Internal Medicine
American Board Of Internal Medicine

Fellowships

University of Kansas School of Medicine

Hospital Affiliations

Upmc Bedford Memorial
Spectrum Health
Upmc Altoona
Conemaugh Nason Medical Center
Penn Highlands Huntingdon

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

UPMC Hillman Cancer Center - Altoona
800 Howard Avenue, Suite 1, Altoona, PA 16601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects
Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects
Enrollment Status: Terminated
Publish Date: August 28, 2025
Intervention Type: Drug
Study Drugs: Brentuximab, Doxorubicin, Vinblastine, Dacarbazine, Nivolumab, Filgrastim
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
Enrollment Status: Completed
Publish Date: January 22, 2025
Intervention Type: Drug, Other
Study Drugs: Tucatinib, Trastuzumab, Ramucirumab, Paclitaxel
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

1 Total Publications

Impact of Curriculum Content on Resident Attitudes Towards Cancer Care.
Impact of Curriculum Content on Resident Attitudes Towards Cancer Care.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: September 21, 2015
Similar Doctors
Expertise in
64
conditions
Dr. Mark M. Keating
Hematology Oncology
Expertise in
64
conditions
Dr. Mark M. Keating
Hematology Oncology
Referral may be required
Before you request

UPMC Hillman Cancer Center - Evertt

195 Memorial Drive, Suite 6, 
Everett, PA 
 (38.3 miles away)
814-631-5993
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Keating, MD, is a medical oncologist specializing in tumors and diseases of the blood. He has a particular expertise in the diagnosis and treatment of gastrointestinal, kidney, bladder, breast, lung, head and neck, and prostate cancers, as well as chronic leukemia, lymphoma, brain tumors, and benign hematologic disorders. Dr. Keating is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Paget Disease of the Breast, and Non-Hodgkin Lymphoma. Dr. Keating is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Keating is currently accepting new patients.

Expertise in
47
conditions
Dr. Ibrahim H. Sbeitan
Hematology Oncology
Expertise in
47
conditions
Dr. Ibrahim H. Sbeitan
Hematology Oncology
Referral may be required
Before you request

UPMC Hillman Cancer Center At John P. Murtha Pavilion

337 Somerset Street, 
Johnstown, PA 
 (33.2 miles away)
814-961-3733
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ibrahim Sbeitan, MD, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center. Dr. Sbeitan received his medical degree from the University of Jordan School of Medicine and completed his residency at Gundersen Medical Foundation in La Crosse, Wisconsin, followed by a fellowship at the University of Pittsburgh School of Medicine. Dr. Sbeitan is highly rated in 47 conditions, according to our data. His clinical expertise encompasses Chronic Familial Neutropenia, Lynch Syndrome, Paget Disease of the Breast, and Urothelial Cancer. Dr. Sbeitan is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Sbeitan is currently accepting new patients.

Expertise in
14
conditions
Dr. Yuanjue-louann L. Zhang
Hematology Oncology
Expertise in
14
conditions
Dr. Yuanjue-louann L. Zhang
Hematology Oncology
Referral may be required
Before you request

UPMC Hillman Cancer Center At UPMC Altoona

800 Howard Avenue, Suite 1, 
Altoona, PA 
 (0.1 miles away)
814-800-2373
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Louann Zhang, MD, is a medical oncologist specializing in all medical oncology and hematology cases. Dr. Zhang is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Intraductal Papilloma, Breast Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Schnitzler Syndrome. Dr. Zhang is board certified in American Board Of Internal Medicine. Dr. Zhang is currently accepting new patients.

Frequently Asked Questions about Dr. Kristopher J. Hansen

How do I make an appointment with Dr. Kristopher J. Hansen?

You can book an appointment with Dr. Kristopher J. Hansen by calling their office at 582-822-4937. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kristopher J. Hansen a top-rated expert for Iron Deficiency Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kristopher J. Hansen is classified as an Advanced expert for Iron Deficiency Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kristopher J. Hansen specialize in?

While Dr. Kristopher J. Hansen is a Hematology Oncology, they have specific expertise in Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Kristopher J. Hansen participate in research or clinical trials?

Yes. Dr. Kristopher J. Hansen has published 1 articles and abstracts on conditions like Iron Deficiency Anemia. You can view a list of Dr. Kristopher J. Hansen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kristopher J. Hansen accept my insurance?

Dr. Kristopher J. Hansen accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 582-822-4937 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hansen's expertise for a condition
ConditionClose
      View All 20 Advanced Conditions
      View All 126 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile